We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
21.7
quarters
Top 10 Avg Time Held
6.6
quarters
Top 20 Avg Time Held
9.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2126
Kura Sushi USA
KRUS
$492M
| – | – |
-6,700
| Closed | -$343K | – |
|
2127
Kohl's
KSS
$2.31B
| – | – |
-734
| Closed | -$6K | – |
|
2128
Key Tronic
KTCC
$23.5M
| – | – |
-95
| Closed | -$245 | – |
|
2129
DELISTED
Leggett & Platt
LEG
| – | – |
-2,755
| Closed | -$21.8K | – |
|
2130
Lennar Class A
LEN
$18.2B
| – | – |
-3,605
| Closed | -$414K | – |
|
2131
LENSAR
LNSR
$78.3M
| – | – |
-672
| Closed | -$9.49K | – |
|
2132
LoveSac
LOVE
$205M
| – | – |
-255,000
| Closed | -$4.64M | – |
|
2133
DELISTED
Open Lending Corp
LPRO
| – | – |
-108,024
| Closed | -$298K | – |
|
2134
Liquidity Services
LQDT
$1.35B
| – | – |
-80
| Closed | -$2.48K | – |
|
2135
Intuitive Machines
LUNR
$2.13B
| – | – |
-41
| Closed | -$305 | – |
|
2136
Mobileye
MBLY
$6.04B
| – | – |
-163,459
| Closed | -$2.35M | – |
|
2137
Madrigal Pharmaceuticals
MDGL
$10.9B
| – | – |
-58,025
| Closed | -$19.2M | – |
|
2138
MDU Resources
MDU
$3.94B
| – | – |
-6,884
| Closed | -$116K | – |
|
2139
MiMedx Group
MDXG
$682M
| – | – |
-36,636
| Closed | -$278K | – |
|
2140
Onterris Inc
ONT
$485M
| – | – |
-24,800
| Closed | -$354K | – |
|
2141
Republic Airways Holdings
RJET
$805M
| – | – |
-4,456
| Closed | -$52.3K | – |
|
2142
MacroGenics
MGNX
$238M
| – | – |
-7,091
| Closed | -$9.01K | – |
|
2143
Marqeta
MQ
$1.89B
| – | – |
-1
| Closed | -$12 | – |
|
2144
Meridian
MRBK
$222M
| – | – |
-279
| Closed | -$4.02K | – |
|
2145
Matrix Service
MTRX
$298M
| – | – |
-577
| Closed | -$7.17K | – |
|
2146
N-able
NABL
$875M
| – | – |
-180
| Closed | -$1.28K | – |
|
2147
NextDecade
NEXT
$1.76B
| – | – |
-92
| Closed | -$716 | – |
|
2148
DELISTED
Inotiv
NOTV
| – | – |
-688
| Closed | -$1.52K | – |
|
2149
Nurix Therapeutics
NRIX
$2.32B
| – | – |
-15
| Closed | -$178 | – |
|
2150
Insight Enterprises
NSIT
$4.8B
| – | – |
-109
| Closed | -$16.3K | – |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.